CHS Inc.
CHS Inc. CHSCN Peers
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $24.80 | -1.94% | 333.8M | N/A | N/A | +7.32% |
| ADM | $52.00 | +4.71% | 25B | 18.31 | $2.84 | +3.91% |
| TSN | $54.80 | -1.56% | 19.1B | 21.32 | $2.57 | +3.63% |
| BG | $81.39 | +5.65% | 10.9B | 10.45 | $7.79 | +3.39% |
| SFD | $23.56 | -1.44% | 9.3B | 10.38 | $2.27 | +2.11% |
| CALM | $96.39 | +1.65% | 4.7B | 4.76 | $20.24 | +6.97% |
| AGRO | $9.29 | -0.38% | 4.6B | 14.74 | $0.63 | +3.78% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | N/A |
| FDP | $32.80 | -0.97% | 1.6B | 10.75 | $3.05 | +3.34% |
| VITL | $31.65 | -1.68% | 1.4B | 28.26 | $1.12 | N/A |
Stock Comparison
CHSCN vs ADM Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, ADM has a market cap of 25B. Regarding current trading prices, CHSCN is priced at $24.80, while ADM trades at $52.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 18.31. In terms of profitability, CHSCN's ROE is +0.05%, compared to ADM's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs TSN Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, TSN has a market cap of 19.1B. Regarding current trading prices, CHSCN is priced at $24.80, while TSN trades at $54.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 21.32. In terms of profitability, CHSCN's ROE is +0.05%, compared to TSN's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs BG Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, BG has a market cap of 10.9B. Regarding current trading prices, CHSCN is priced at $24.80, while BG trades at $81.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 10.45. In terms of profitability, CHSCN's ROE is +0.05%, compared to BG's ROE of +0.11%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs SFD Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, SFD has a market cap of 9.3B. Regarding current trading prices, CHSCN is priced at $24.80, while SFD trades at $23.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 10.38. In terms of profitability, CHSCN's ROE is +0.05%, compared to SFD's ROE of +0.08%. Regarding short-term risk, CHSCN is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs CALM Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, CALM has a market cap of 4.7B. Regarding current trading prices, CHSCN is priced at $24.80, while CALM trades at $96.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 4.76. In terms of profitability, CHSCN's ROE is +0.05%, compared to CALM's ROE of +0.49%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AGRO Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AGRO has a market cap of 4.6B. Regarding current trading prices, CHSCN is priced at $24.80, while AGRO trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 14.74. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRO's ROE of +0.07%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs IBA Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $24.80, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs FDP Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, FDP has a market cap of 1.6B. Regarding current trading prices, CHSCN is priced at $24.80, while FDP trades at $32.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 10.75. In terms of profitability, CHSCN's ROE is +0.05%, compared to FDP's ROE of +0.07%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs VITL Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, VITL has a market cap of 1.4B. Regarding current trading prices, CHSCN is priced at $24.80, while VITL trades at $31.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 28.26. In terms of profitability, CHSCN's ROE is +0.05%, compared to VITL's ROE of +0.20%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs DOLE Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, DOLE has a market cap of 1.3B. Regarding current trading prices, CHSCN is priced at $24.80, while DOLE trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 11.38. In terms of profitability, CHSCN's ROE is +0.05%, compared to DOLE's ROE of +0.09%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs LND Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, LND has a market cap of 378.5M. Regarding current trading prices, CHSCN is priced at $24.80, while LND trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is 6.79. In terms of profitability, CHSCN's ROE is +0.05%, compared to LND's ROE of +0.14%. Regarding short-term risk, CHSCN is more volatile compared to LND. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs CHSCP Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, CHSCP has a market cap of 335M. Regarding current trading prices, CHSCN is priced at $24.80, while CHSCP trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCP's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCP. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs CHSCL Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, CHSCL has a market cap of 334.6M. Regarding current trading prices, CHSCN is priced at $24.80, while CHSCL trades at $25.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCL's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs CHSCM Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, CHSCM has a market cap of 330.4M. Regarding current trading prices, CHSCN is priced at $24.80, while CHSCM trades at $24.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to CHSCM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs CHSCO Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, CHSCO has a market cap of 325.2M. Regarding current trading prices, CHSCN is priced at $24.80, while CHSCO trades at $26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCN is more volatile compared to CHSCO. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs LMNR Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, LMNR has a market cap of 278.3M. Regarding current trading prices, CHSCN is priced at $24.80, while LMNR trades at $15.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -118.46. In terms of profitability, CHSCN's ROE is +0.05%, compared to LMNR's ROE of +0.04%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs ALCO Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, ALCO has a market cap of 239.7M. Regarding current trading prices, CHSCN is priced at $24.80, while ALCO trades at $31.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -1.70. In terms of profitability, CHSCN's ROE is +0.05%, compared to ALCO's ROE of -0.63%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AFRI Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AFRI has a market cap of 208.2M. Regarding current trading prices, CHSCN is priced at $24.80, while AFRI trades at $7.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -8.90. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRI's ROE of -1.48%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AGFS Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $24.80, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is more volatile compared to AGFS. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs VFF Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, VFF has a market cap of 119.6M. Regarding current trading prices, CHSCN is priced at $24.80, while VFF trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is -3.04. In terms of profitability, CHSCN's ROE is +0.05%, compared to VFF's ROE of -0.15%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs LOCL Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, LOCL has a market cap of 23.4M. Regarding current trading prices, CHSCN is priced at $24.80, while LOCL trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.05%, compared to LOCL's ROE of +1.61%. Regarding short-term risk, CHSCN is more volatile compared to LOCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs PME Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $24.80, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs DTCK Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, DTCK has a market cap of 19.8M. Regarding current trading prices, CHSCN is priced at $24.80, while DTCK trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -5.78. In terms of profitability, CHSCN's ROE is +0.05%, compared to DTCK's ROE of +0.04%. Regarding short-term risk, CHSCN is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs SANW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, SANW has a market cap of 11.8M. Regarding current trading prices, CHSCN is priced at $24.80, while SANW trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SANW's P/E ratio is -0.40. In terms of profitability, CHSCN's ROE is +0.05%, compared to SANW's ROE of -1.24%. Regarding short-term risk, CHSCN is less volatile compared to SANW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs SDOT Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, SDOT has a market cap of 10.7M. Regarding current trading prices, CHSCN is priced at $24.80, while SDOT trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is 1.41. In terms of profitability, CHSCN's ROE is +0.05%, compared to SDOT's ROE of +0.15%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs APPH Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $24.80, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs APPHW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $24.80, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AFRIW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AFRIW has a market cap of 9.8M. Regarding current trading prices, CHSCN is priced at $24.80, while AFRIW trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -15.89. In terms of profitability, CHSCN's ROE is +0.05%, compared to AFRIW's ROE of -1.48%. Regarding short-term risk, CHSCN is less volatile compared to AFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs EDBLW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, EDBLW has a market cap of 6M. Regarding current trading prices, CHSCN is priced at $24.80, while EDBLW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.08. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBLW's ROE of -4.25%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs EDBL Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, EDBL has a market cap of 4.8M. Regarding current trading prices, CHSCN is priced at $24.80, while EDBL trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is 0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to EDBL's ROE of -4.25%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AQB Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AQB has a market cap of 3.3M. Regarding current trading prices, CHSCN is priced at $24.80, while AQB trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.03. In terms of profitability, CHSCN's ROE is +0.05%, compared to AQB's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AGRI Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AGRI has a market cap of 3.2M. Regarding current trading prices, CHSCN is priced at $24.80, while AGRI trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is -0.30. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRI's ROE of +0.10%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs KAL Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $24.80, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs KALWW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $24.80, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AAGR Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AAGR has a market cap of 578.7K. Regarding current trading prices, CHSCN is priced at $24.80, while AAGR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGR's ROE of +1.14%. Regarding short-term risk, CHSCN is more volatile compared to AAGR. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AAGRW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AAGRW has a market cap of 578.7K. Regarding current trading prices, CHSCN is priced at $24.80, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.05%, compared to AAGRW's ROE of +1.14%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.
CHSCN vs AGRIW Comparison
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 333.8M. In comparison, AGRIW has a market cap of 69.2K. Regarding current trading prices, CHSCN is priced at $24.80, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.05%, compared to AGRIW's ROE of +0.10%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.